Loading... Please wait...

MEDIROM Healthcare Technologies Inc. (MRM) Stock Price, News & Analysis

Currency in USD Disclaimer
$4.39 $0.49 (12.56%)
$4.01
$4.44
$3.4
$7.4

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company


  • Altman Z Score -0.28
  • Piotroski Score 2.00
  • Grade N/A

Company brief: MEDIROM Healthcare Technologies Inc. (MRM)


MEDIROM Healthcare Technologies Inc. provides holistic healthcare services in Japan. It operates in two segments, Relaxation Salon and Digital Preventative Healthcare. The Relaxation Salon segment owns and franchises relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. As of December 31, 2021, this segment operated 312 relaxation salons under the Re.Ra.Ku and Ruam Ruam brand. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program, utilizing Lav, its internally developed on-demand health monitoring smartphone application; MOTHER Tracker for fitness applications; and preventative healthcare services utilizing its digital application and devices. MEDIROM Healthcare Technologies Inc. also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques located in the Odaiba area in Tokyo. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.

Morningstar - News Details (View)

Details

  • Quant star rating 3
  • A 3-star rating suggests average performance compared to other similar companies.

  • Quant star rating date 07/02/2024
  • Quant economic moat label Narrow
  • Quant economic moat date 07/03/2024
  • The economic moat refers to the competitive advantage a company has over its competitors. A narrow moat suggests that the company has a less sustainable competitive advantage compared to those with wider moats.

  • Price over quant fair value $0.60
  • Price over quant fair value date 07/03/2024
  • Quant fair value $7.28
  • Quant valuation Undervalued
  • Quant fair value date 07/03/2024
  • This ratio indicates whether the stock is trading above (greater than 1) or below (less than 1) its fair value as determined by Morningstar's quantitative analysis. A ratio of 0.94 suggests the stock is currently trading at a slight discount (undervalued).

  • Quant fair value uncertainty label Very High
  • Significant uncertainty in fair value estimates indicates substantial potential volatility in the stock price. Investors should carefully consider their risk tolerance and long-term investment strategy when evaluating stocks with this level of uncertainty.

  • One star price $15.65
  • Quant fair value uncertainty date 07/03/2024
  • These price estimates indicate the price levels at which Morningstar would consider the stock significantly overvalued (one-star) or undervalued (five-star) based on their analysis.

  • One star price date 07/03/2024
  • Five star price $3.38
  • Five star price date 07/03/2024
  • Quant financial health label Moderate
  • Quant financial health date 07/03/2024
  • Moderate financial health suggests stability but also indicates potential risks. Evaluate the company's ability to manage its financial obligations and fund growth initiatives.

Investment Considerations:

Valuation vs. Price: The stock is currently considered undervalued relative to its fair value, which could present a buying opportunity if you believe in Morningstar's valuation methodology.

Moat and Competitive Position: The narrow economic moat indicates less sustainable competitive advantages. Consider whether the company's business model and market position align with your investment goals.

Financial Health: Moderate financial health suggests stability but also indicates potential risks. Evaluate the company's ability to manage its financial obligations and fund growth initiatives.

Uncertainty: High uncertainty in fair value estimates implies potential volatility in the stock price. Factor in your risk tolerance and investment horizon when assessing this uncertainty.


Price Target and Rating


  • $0.00
  • $0.00
  • $0.00
  • N/A
  • Neutral
  • N/A
  • N/A

Profitability


  • -$0.05
  • -105.85
  • -105.85
  • -105.85
  • $115.05 M

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.


Latest News of MRM

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.


Significant uncertainty in fair value estimates indicates substantial potential volatility in the stock price. Investors should carefully consider their risk tolerance and long-term investment strategy when evaluating stocks with this level of uncertainty.
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.